Sign Up to like & get
recommendations!
1
Published in 2020 at "Blood advances"
DOI: 10.1182/bloodadvances.2020002547
Abstract: T cells engineered with chimeric antigen receptors (CARs) have revolutionized the field of cell therapy and changed the paradigm of treatment for many patients with relapsed or refractory B-cell malignancies. Despite this progress, there are…
read more here.
Keywords:
cell therapies;
therapies emerging;
generation cell;
next generation ... See more keywords